- Home
- KZIA vs NCSM Comparison
KZIA vs NCSM Comparison
Compare KZIA & NCSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KZIA | NCSM |
|---|---|---|
| Founded | 1994 | 2006 |
| Country | Australia | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oilfield Services/Equipment |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 100.8M | 112.0M |
| IPO Year | 2002 | 2017 |
Fundamental Metrics
Financial Performance| Metric | KZIA | NCSM |
|---|---|---|
| Price | $14.63 | $45.26 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $19.50 | N/A |
| AVG Volume (30 Days) | ★ 188.8K | 31.3K |
| Earning Date | 06-04-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 239.22 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $142,471,000.00 |
| Revenue This Year | N/A | $5.57 |
| Revenue Next Year | N/A | $4.81 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.86 | $28.73 |
| 52 Week High | $17.40 | $87.36 |
Technical Indicators
Market Signals| Indicator | KZIA | NCSM |
|---|---|---|
| Relative Strength Index (RSI) | 64.05 | 37.12 |
| Support Level | $5.62 | $35.60 |
| Resistance Level | $17.40 | $45.87 |
| Average True Range (ATR) | 1.06 | 2.23 |
| MACD | 0.23 | -0.51 |
| Stochastic Oscillator | 89.70 | 0.00 |
Price Performance
Historical ComparisonAbout KZIA Kazia Therapeutics Limited
Kazia Therapeutics Ltd is a biotechnology company focused on pharmaceutical drug development in oncology. The company has a portfolio of development candidates across various technologies targeting multiple cancer indications. Its primary program is Paxalisib, an investigational brain-penetrant inhibitor of the PI3K/Akt/mTOR pathway, designed for the treatment of brain cancer. The company develops targeted therapies aimed at addressing medical needs in oncology. The company operates in Australia and the United States.
About NCSM NCS Multistage Holdings Inc.
NCS Multistage Holdings Inc is a provider of engineered products and support services that facilitate the optimization of oil and natural gas well construction, well completion, and field development strategies. The company provides its products and services to E&P companies for use in onshore and offshore wells, predominantly those drilled with horizontal laterals in unconventional and conventional oil and natural gas formations. It also provides tracer diagnostics services and sells products for well construction including casing buoyancy systems, liner hanger systems and toe initiation sleeves, along with certain complementary products from third parties. The company operates in the United States, Canada and other countries, with the majority of its revenue generated from Canada.